Centre National De La Recherche Scientifique

Total Research & Technology Feluy

Université De Caen Normandie

Sanofi Pasteur Inc.

Ecole Nationale Superieure D Ingenieurs De Caen

Valentin Valtchev

Nikolai Nesterenko

Jean-Pierre Dath

Delphine Minoux

Svetlana Mintova Lazarova

Kok-Giap Haw

Jean-Michel Goupil

Joel Patarin

Jean Haensler

Joël Patarin

Jean-Pierre Gilson

Svetlana Mintova

Elisabeth Sauzeat

Yannick Mathieu

Marie Garinot

Samuel Valable

Clément Anfray

Omar Touzani

Myriam Bernaudin

Kamila Goldyn

Zhengxing Qin

Hussein Awala

Benedicte Lebeau

Bénédicte Lebeau

The present invention relates to a method of post-synthetic downsizing zeolite-type crystals and/or agglomerates thereof to nanosized particles, and in particular a heating-free and chemical-free method. The present invention also relates to nanosized particles of zeolite-type material capable of being obtained by the method of the invention and to the use of such particles as a catalyst or catalyst support for heterogeneous catalyst, or as molecular sieve, or as a cation exchanger.

Post-synthetic downsizing zeolite-type crystals and/or agglomerates thereof to nanosized particles

The present invention relates to a method for the preparation of a colloidal aqueous suspension of stable zeolite nanocrystals having framework structures comprising at least one cation selected from Gd, Fe, Cu and Ce, said structures being loaded with a gas selected from O, COand mixtures thereof, to the colloidal aqueous suspension of zeolite nanocrystals obtained by such a process, and to the use of said suspension in therapy, more particularly in cancer therapy and hypoxia-related diseases and/or in diagnosis.

Process for the preparation of a suspension of nanosized synthetic zeolite materials, suspensions of nanosized synthetic zeolite materials obtained by said process and their uses in therapy and diagnosis

The present invention relates to a method for the preparation of faujasite nanocrystals, to faujasite nanocrystals, to a method for the preparation of a stable colloidal suspension of faujasite nanocrystals, to a stable colloidal suspension of faujasite nanocrystals, and to the use of said faujasite nanocrystals and said stable colloidal suspension of faujasite nanocrystals in various applications.

Method for the preparation of a synthetic faujasite material comprising monodisperse nanoparticles composed of single nanocrystals

Catalyst compositions comprising an inorganic porous material with pore diameters of at least 2 nm and of crystals of molecular sieve, characterized in that the crystals of molecular sieve have an average diameter, measured by scanning electron microscopy, not bigger than 50 nm, and in that the catalyst composition presents a concentration of acid sites ranges from 50 to 1200 &#x3bc;mol/g measured by TPD NH3 adsorption; and the XRD pattern of said catalyst composition is the same as the X ray diffraction pattern of said inorganic porous material.

Catalyst compositions comprising small size molecular sieves crystals deposited on a porous material

The present invention relates to a method for the preparation of a synthetic crystalline zeolite material, to said synthetic crystalline zeolite material, and to the uses of said method and said synthetic crystalline zeolite material in various applications.

Method for the preparation of synthetic crystalline zeolite materials with enhanced pore volume

A catalyst composition contains an inorganic porous material with pore diameters of at least 2 nm and of crystals of molecular sieve. The crystals of molecular sieve have an average diameter, measured by scanning electron microscopy, not bigger than 50 nm. The catalyst composition has a concentration of acid sites ranges from 50 to 1200 &#x3bc;mol/g measured by TPD NH3 adsorption. An XRD pattern of the catalyst composition is the same as an XRD pattern of the inorganic porous material.

A vaccine composition comprising at least one antigen and one adjuvant, characterized in that the adjuvant comprises sterile-filterable nanoparticles comprising pseudo-boehmite and polyacrylate.

Vaccine composition with aluminium hydroxide nanoparticles

Growing community of inventors

Basly, France

Valentin Valtchev